164 related articles for article (PubMed ID: 21447974)
1. Surveillance results of patients with stage I nonseminomatous germ cell testicular cancer.
Keskin S; Ekenel M; Başaran M; Bavbek S
Onkologie; 2011; 34(4):173-6. PubMed ID: 21447974
[TBL] [Abstract][Full Text] [Related]
2. Surveillance for patients with clinical stage I nonseminomatous testicular germ cell tumors.
Li X; Guo S; Wu Z; Dong P; Li Y; Zhang Z; Yao K; Han H; Qin Z; Zhou F; Liu Z
World J Urol; 2015 Sep; 33(9):1351-7. PubMed ID: 25471669
[TBL] [Abstract][Full Text] [Related]
3. Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.
Sturgeon JF; Moore MJ; Kakiashvili DM; Duran I; Anson-Cartwright LC; Berthold DR; Warde PR; Gospodarowicz MK; Alison RE; Liu J; Ma C; Pond GR; Jewett MA
Eur Urol; 2011 Apr; 59(4):556-62. PubMed ID: 21190791
[TBL] [Abstract][Full Text] [Related]
4. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.
Spiess PE; Brown GA; Liu P; Tu SM; Tannir NM; Evans JG; Kamat AM; Kassouf W; Pisters LL
J Urol; 2007 Jan; 177(1):131-8. PubMed ID: 17162023
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
Divrik RT; Akdoğan B; Ozen H; Zorlu F
J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
[TBL] [Abstract][Full Text] [Related]
6. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
[TBL] [Abstract][Full Text] [Related]
7. [Testicular germ cell tumors, the state of diagnostics and staging in Saint-Petersburg].
Nosov AK; Gafton GI; Meraboshvili VM; Mamizhev ÉM; Vorob'ev AV; Petrov SB
Vopr Onkol; 2012; 58(2):238-42. PubMed ID: 22774531
[TBL] [Abstract][Full Text] [Related]
8. Retroperitoneal lymphadenectomy remains the treatment of choice in nonseminomatous germ cell tumors.
Graham SD
Semin Urol; 1993 May; 11(2):85-91. PubMed ID: 8395700
[No Abstract] [Full Text] [Related]
9. Surveillance alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis (NSGCT).
Sogani PC; Fair WR
Semin Urol; 1988 Feb; 6(1):53-6. PubMed ID: 2838876
[No Abstract] [Full Text] [Related]
10. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.
Ellinger J; Albers P; Müller SC; von Ruecker A; Bastian PJ
BJU Int; 2009 Jul; 104(1):48-52. PubMed ID: 19154496
[TBL] [Abstract][Full Text] [Related]
11. Surveillance in patients with stage I nonseminomatous testicular tumors.
Litwin MS; Richie JP
Surg Annu; 1994; 26():89-99. PubMed ID: 8303525
[No Abstract] [Full Text] [Related]
12. Appropriateness of testicular cancer management: a population-based cohort study.
Cheung WY; Demers A; Hossain D; Owen T; Ahmed S; Czaykowski PM
Can J Urol; 2007 Jun; 14(3):3542-50. PubMed ID: 17594744
[TBL] [Abstract][Full Text] [Related]
13. Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review.
Chakiryan NH; Dahmen A; Cucchiara V; Briganti A; Montorsi F; Salonia A; Spiess PE; Necchi A
J Urol; 2021 Jun; 205(6):1569-1576. PubMed ID: 33617328
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
[TBL] [Abstract][Full Text] [Related]
15. [Clinical presentation of testicular germinal cancer].
Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
[TBL] [Abstract][Full Text] [Related]
16. Surveillance for clinical stage I nonseminomatous testis carcinoma: rationale and results.
Stephenson RA
Urol Int; 1991; 46(3):290-3. PubMed ID: 1656576
[TBL] [Abstract][Full Text] [Related]
17. Cancer of the testis: a new paradigm.
Einhorn LH
Hosp Pract (Off Ed); 1986 Apr; 21(4):165-72, 175-8. PubMed ID: 2420812
[No Abstract] [Full Text] [Related]
18. Active surveillance after orchiectomy for nonseminomatous testicular germ cell tumors: late relapse may occur.
Boyer MJ; Cox K; Tattersall MH; Findlay MP; Grygiel J; Rogers J
Urology; 1997 Oct; 50(4):588-92. PubMed ID: 9338737
[TBL] [Abstract][Full Text] [Related]
19. Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases.
Dieckmann KP; Albers P; Classen J; De Wit M; Pichlmeier U; Rick O; Müllerleile U; Kuczyk M
J Urol; 2005 Mar; 173(3):824-9. PubMed ID: 15711278
[TBL] [Abstract][Full Text] [Related]
20. Surgical aspects in the treatment of patients with testicular cancer.
Richie JP
Hematol Oncol Clin North Am; 1991 Dec; 5(6):1127-42. PubMed ID: 1663937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
